
Opinion|Videos|May 3, 2024
Treating a DME Patient Lost to Follow-Up with a Highly Durable Agent
Katherine Talcott, MD, presents the case of a patient with diabetic macular edema, and the rest of the panel share their clinical experiences and discuss factors that inform the utilization of more durable agents.
Advertisement
Episodes in this series

Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Increasing the knowledge base of GA is key to individualizing patient therapy
2
EYDENZELT, Celltrion’s biosimilar referencing EYLEA, approved by FDA
3
REGENXBIO completes enrollment in ATMOSPHERE and ASCENT trials of sura-vec in wet AMD
4
Quantifying intermittent retinal capillary perfusion in RVO and PDR
5